ProCE Banner Activity

Tardive Dyskinesia: How to Help Your Patients Manage an Aging-Related Risk

Clinical Thought

A geropsychiatric expert discusses the growing risk of tardive dyskinesia (TD) in an aging population with chronic psychiatric conditions. Learn to identify risk factors and evaluate treatment options to optimize health and quality of life for patients with TD.

Released: July 16, 2024

Expiration: July 15, 2025

Share

Faculty

Martha Sajatovic

Martha Sajatovic, MD

Professor of Psychiatry and of Neurology
Willard Brown Chair in Neurological Outcomes Research
Rocco L. Motto Professorship in Child & Adolescent Psychiatry
Director, Neurological and Behavioral Outcomes Center
University Hospitals Cleveland Medical Center
Case Western Reserve University School of Medicine
Cleveland, Ohio

Provided by

Provided by Clinical Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc.

Faculty Disclosure

Primary Author

Martha Sajatovic, MD

Professor of Psychiatry and of Neurology
Willard Brown Chair in Neurological Outcomes Research
Rocco L. Motto Professorship in Child & Adolescent Psychiatry
Director, Neurological and Behavioral Outcomes Center
University Hospitals Cleveland Medical Center
Case Western Reserve University School of Medicine
Cleveland, Ohio

Martha Sajatovic, MD: researcher: Alkermes, Intra-Cellular, Merck, Neurelis, Otsuka; consultant/advisor/speaker: Alkermes, Janssen, Lundbeck, Neurelis, Otsuka, Teva.